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Background/aim: To compare the central corneal thickness (CCT) of type II diabetes mellitus patients with age- and sex-matched
healthy subjects and to determine the association of the severity of diabetic retinopathy and CCT.
Materials and methods: Type II diabetes mellitus patients without retinopathy, with nonproliferative retinopathy, and with proliferative
retinopathy were organized as the three subgroups of the study group, and an age- and sex-matched control group was formed. All
subjects underwent full ophthalmological examination and CCT measurement with ultrasonographic pachymetry. CCT values were
compared between diabetic and healthy subjects and between the three diabetic subgroups. Correlation analysis was performed to
determine any relationship between CCT and intraocular pressure.
Results: The average CCT was significantly higher in diabetic patients than in the control group (P = 0.04). CCT in diabetic patients
without retinopathy did not significantly differ from that of patients with retinopathy (P = 0.64). Similarly, there was no significant
difference in CCT between nonproliferative and proliferative diabetic retinopathy patients (P = 0.47). In the whole study population,
CCT was significantly correlated with intraocular pressure (P < 0.01).
Conclusion: CCT is significantly increased in type II diabetes mellitus patients with respect to controls. Retinal disease severity does not
seem to have an effect on corneal thickness.
Key words: Central corneal thickness, diabetes mellitus, diabetic retinopathy, pachymetry

1. Introduction
With well-documented ocular complications, diabetes
mellitus (DM) is a leading cause of blindness throughout the
world. Although investigations in DM are mostly focused
on retinal damage, corneal alterations associated with DM
have also been reported (1–4). Prolonged abnormal glucose
metabolism results in alterations in the epithelium, stroma,
and endothelium of the cornea (5). Central corneal thickness
(CCT), which reflects the metabolic status of the cornea, is
also influenced by DM (6). These diabetic changes in the
cornea might have an influence on intraocular pressure
(IOP) measurements. Therefore, in diabetic patients, accurate
detection of IOP could be problematic and challenging (7).
In the current study, we aimed to analyze CCT in type
II DM patients and to compare the results with age- and
sex-matched healthy controls. We also investigated the
association of retinal disease severity and CCT among
diabetic patients.
* Correspondence: ozgeyabas@hotmail.com

2. Materials and methods
The study was done at the Başkent University
Adana Research and Clinic Center Department of
Ophthalmology. Patients with type II (noninsulindependent) DM, who were admitted to our outpatient
clinic, were screened for eligibility for the study. A patient
who had a referring-physician diagnosis of type II DM
and who was given antidiabetic medication was defined
as diabetic. Subjects with a prior history of ocular surgery,
ocular surface disease, glaucoma, or uveitis and patients
who had a history of chronic topical medication use were
not involved in the study. Likewise, past or present contact
lens wearers were excluded.
This prospective clinical study was consistent with the
tenets of the Declaration of Helsinki. Local ethics committee
approval was obtained. All patients were informed of the
risks and benefits of the procedure and a written informed
consent form was obtained from all participants.
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Two hundred seventeen eyes of 217 patients were
enrolled. One eye from each patient was used for analysis.
Patients with DM were assigned into 3 groups: the first
group included 59 patients ranging between the ages of
34 and 75 years (mean: 55 ± 9.8 years) with no diabetic
retinopathy (DR), the second group included 55 patients
ranging between the ages of 38 and 78 years (mean: 57.1
± 8.3 years) with nonproliferative diabetic retinopathy
(NPDR), and the third group included 51 patients ranging
between the ages of 41 and 74 years (mean: 56.3 ± 7.2
years) with proliferative diabetic retinopathy (PDR). The
control group consisted of 52 age- and sex-matched
healthy subjects ranging between the ages of 38 and 75
years (mean: 56.1 ± 7.5 years). The differentiation of
NPDR and PDR was made as previously reported by the
Early Treatment Diabetic Retinopathy Study Research
Group (8).
All patients underwent full ophthalmological
examination, including thorough biomicroscopic indirect
fundoscopy through the mydriatic pupil. Intraocular
pressure was measured by Goldmann’s applanation
tonometer. Data on age and sex were recorded. Fundus
fluorescein angiography was performed whenever
necessary (9). CCT was measured by ultrasonographic
pachymetry (UP-1000 Ultrasonic Pachymeter, Nidek
Co., Aichi, Japan) under topical anesthesia. The average
of 5 consecutive readings was recorded. All pachymetry
measurements were performed by the same technician
between 1000 and 1200 hours to eliminate diurnal
variation in corneal thickness.

For statistical analysis, SPSS 11.0 for Windows (SPSS
Inc., Chicago, IL, USA) was used. By the Kolmogorov–
Smirnov test, the distribution function of the sample was
analyzed. In the groups, age, severity of DR, and CCT were
compared by ANOVA. Different groups were assigned by
post hoc Tukey HSD test. Independent t-test was used
to assess the differences among measurements in the 4
groups and the Pearson correlation coefficient was used
to investigate the correlation between DM and corneal
thickness. The level of significance was set at P < 0.05.
3. Results
The male/female ratio of groups 1, 2, and 3 and the
controls were 23/36, 28/27, 27/24, and 31/21, respectively.
There was no statistical significance by means of age or sex
between groups (P = 0.63 and P = 0.34, respectively).
The mean CCT values of each group are given in Table
1. The average CCT was significantly higher in diabetic
patients (including all 3 groups) than in the control group
(P = 0.04). However, CCT in diabetic patients without
retinopathy did not significantly differ from those of
patients with retinopathy (P = 0.64). Similarly, there was
no significant difference in CCT between NPDR and PDR
patients (P = 0.47).
According to the correlation analysis, in the whole
cohort, CCT was significantly correlated with IOP (P <
0.01). These two parameters were significantly correlated
in both diabetic patients and the controls (r = 0.279,
P < 0.01 and r = 0.517, P < 0.01, respectively). Table 2
demonstrates the IOP values of groups. Mean IOP values

Table 1. Central corneal thickness (µm) values of groups
N (eyes)

Mean CCT

Group 1

59

Group 2

95% confidence interval
Lower bound

Upper bound

552.5 ± 38.0

542.5

562.4

55

560.0 ± 32.3

551.3

568.7

Group 3

51

550.1 ± 38.3

539.3

560.8

Controls

52

542.7 ± 31.6

533.9

551.5

Table 2. Intraocular pressure values (mmHg) of groups.
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N (eyes)

Mean IOP

Group 1

59

Group 2

95% confidence interval
Lower bound

Upper bound

17.1 ± 3.8

16.1

18.1

55

16.4 ± 3.3

15.5

17.3

Group 3

51

15.6 ± 4.0

14.5

16.7

Controls

52

15.5 ± 3.4

14.6

16.4
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were higher in diabetic patients than in controls; however,
the difference was not significant (P = 0.061)
4. Discussion
DM affects the corneal endothelium by altering sodium–
potassium ATPase activity; thus, functional changes occur
in diabetic corneas (4,10,11). Corneal thickening in both
type I and II DM was reported in several studies (2,4,12–
15). This increase in corneal thickness reflects the altered
functional status of the corneal endothelium and may lead
to falsely high IOP measurements.
In this current study, we established age- and sexmatched groups. According to our results, we found
thicker corneas in type II diabetic patients. Similarly,
Su et al. found that hyperglycemia was associated with
increased CCT in their study and explained this finding
with mechanisms such as corneal endothelial dysfunction,
stromal hydration, and swelling of the cornea (15). Lee
et al. reported higher CCT in insulin-dependent DM
patients compared to controls (4). Roszkowska et al.
compared diabetic subjects who had background diabetic
retinopathy with healthy controls and found thicker
CCT in the diabetic group (2). Ozdamar et al. also found
thicker central corneas among diabetics with respect to
nondiabetic controls (14). Recently, Storr-Paulsen et al.
studied 107 patients with type II DM and 128 nondiabetic
controls and concluded that CCT was increased among
type II diabetes patients compared to controls (13).
In a similar study among type I DM patients, Keoleian
et al. found that corneal thickness of type I diabetes
patients did not significantly differ from the age-matched
nondiabetic control subjects. However, they found altered
morphology of the endothelium among diabetics (16).
Likewise, Inoue et al. and Wiemer et al. did not report any
differences in CCT between diabetics and controls (17,18).
In the current study, no significant difference was found
in CCT between the three diabetic subgroups. Busted et al.
and Wiemer et al. also found that CCT increased in DM
regardless of the severity of the retinal disease (12,18).
Ozdamar et al. reported in their study that patients with

proliferative retinopathy had thicker CCT than those with
nonproliferative retinopathy and no retinopathy; however,
the difference was not statistically significant (14).
Other than corneal hydration and swelling, the
increase in CCT may also be a result of increased collagen
crosslinking due to the accumulation of advanced
glycosylation end products, a process related both to
diabetes and normal aging. Collagen crosslinking may
lead to corneal thickening and gradual stiffening of the
cornea and consequently affect the accuracy of IOP
measurements (19). The influence of CCT and corneal
biomechanics on IOP measurement was shown in a study
by Broman et al. (20).
In the current study, CCT was found to be significantly
correlated with IOP, as expected. Average IOP values of the
diabetic subjects were also higher than those of the healthy
controls; however, this difference was not statistically
significant. Results of studies with large series have shown
that DM is associated with high IOP measurements (21,22).
Both increased CCT and increased corneal stiffness due to
collagen crosslinking cause overestimation of the IOP in
diabetic patients; therefore, diabetes may have a preventive
effect on glaucoma progression (5,7). Nevertheless, we
think that diabetic patients must be closely followed
for IOP rise or glaucoma progression, because, in daily
practice, IOP readings might sometimes be overlooked, as
the physician usually focuses on retinopathy.
In conclusion, we found increased CCT in type II
DM regardless of the severity of the retinal disease. This
increase in CCT was correlated with IOP. In our opinion,
increased corneal thickness should be kept in mind when
measuring and evaluating IOP in diabetic patients. It
should be investigated in further studies whether corneal
thickness could be an indicator of the metabolic status of
DM.
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